Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
OVERLAP
11%
OVERLAP
BY WEIGHT
11
# OF OVERLAPPING
HOLDINGS
BMED
61
HOLDINGS
22%
ALSO IN HELX
HELX
66
HOLDINGS
19%
ALSO IN BMED
SECTOR DRIFT (BMED minus HELX)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BMED |
Weight in HELX |
Overlap | |
|---|---|---|---|---|
| VERTEX PHARMACEUTICALS INC | 3.0% | 2.8% | 2.8% | |
| NEUROCRINE BIOSCIENCES INC | 2.2% | 1.9% | 1.9% | |
| ASTRAZENECA PLC | 1.5% | 2.7% | 1.5% | |
| CHARLES RIVER LABORATORIES | 3.2% | 1.1% | 1.1% | |
| AXSOME THERAPEUTICS, INC. | 1.6% | 0.9% | 0.9% | |
BMED Overweight Relative to HELX
| MERCK & CO. INC. | 5.6% | |
| GILEAD SCIENCES INC | 5.0% | |
| JOHNSON & JOHNSON | 5.0% | |
| EDWARDS LIFESCIENCES CORP | 4.9% | |
| BIOGEN IDEC INC | 3.7% | |
| MODERNA, INC. | 3.7% | |
| WATERS CORP | 3.6% | |
| AMGEN INC | 3.4% | |
| METTLER-TOLEDO INTERNATIONAL | 3.1% | |
| DANAHER CORP | 3.0% |
BMED Underweight Relative to HELX
| GUARDANT HEALTH, INC. | -8.8% | |
| NATERA INC | -7.0% | |
| KRYSTAL BIOTECH, INC. | -6.5% | |
| LIGAND PHARMACEUTICALS-CL B | -4.4% | |
| UNITED THERAPEUTICS CORP | -3.8% | |
| ADAPTIVE BIOTECHNOLOGIES CORP. | -3.6% | |
| BRIDGEBIO PHARMA, INC. | -3.4% | |
| ELI LILLY & CO | -3.0% | |
| TRAVERE THERAPEUTICS, INC. | -2.8% | |
| TWIST BIOSCIENCE CORP. | -2.7% |